Synthetic biology techniques have emerged as transformative tools in the tug-of-war between humans and drug-resistant ...

The goal is to create a balance with a specific composition of bacteria and bacteriophages, which provides an important standardization. This standardization makes the treatment scalable and safer ...

Morrisville-based Locus Biosciences, a developer of precision antibacterial therapies, will conduct the world’s first clinical trial of a recombinant bacteriophage therapy, a major milestone for the ...

With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion.

Bacteria-eating viruses called bacteriophages are drawing new interest, Lina Zeldovich writes in “The Living Medicine.” ...

which has already shown promise in the treatment of urinary tract infections (UTIs) caused by resistant E coli. Bacteriophages are viruses that solely and selectively target and kill bacteria and ...

The goal is to create a balance with a specific composition of bacteria and bacteriophages, which provides an important standardization. This standardization makes the treatment scalable and safer ...

Elders named the bacteriophage in Woi Wurrung language ... which are often a "last resort" treatment for bacterial infections. The partnership of Traditional Owners and Monash University ...

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

Urinary tract infections (UTIs), particularly a type called cystitis, are a painful and common issue that affects half of all ...